Ultra Low Temperature Packaging Solutions

Advanced therapy medicinal products (ATMPs) are reshaping the treatment landscape for patients with rare and complex diseases, but their potential can only be realized when highly sensitive products reach patients without compromising quality. For therapies requiring ultra-low temperature storage, every stage of the supply chain presents unique challenges, from packaging and labeling to distribution and patient-specific delivery requirements.

One multinational pharmaceutical company faced exactly this challenge when preparing a gene therapy launch across Europe. With more than 420 patient-specific SKUs, strict ultra-low temperature requirements and country-specific packaging needs, maintaining product integrity throughout the process demanded meticulous planning, specialized expertise and robust operational controls.

Discover how a tailored packaging and distribution strategy enabled seamless processing, quality oversight and direct-to-patient delivery, helping ensure life-changing therapy reached patients on time and in optimal condition despite an exceptionally complex supply chain.